ERC-2019-POC
ERC-2019-POC
Programme: H2020
199 projects · €29,850,000 total EU contribution (project-level) · 139 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€29,850,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (20)
- Italy (17)
- Spain (15)
- Netherlands (15)
- Germany (13)
- France (13)
- AT (6)
- BE (6)
- CH (4)
- FI (4)
- IE (4)
- IL (4)
- DK (3)
- HU (3)
- PT (3)
- RO (2)
- CA (1)
- CZ (1)
- EL (1)
- LU (1)
- SE (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- CNRS10 projects · FR
- EPFL8 projects · CH
- CNRS INNOVATION6 projects · FR
- UNIVERSITY COLLEGE LONDON5 projects · UK
- WEIZMANN5 projects · IL
- AMC4 projects · NL
- IIT4 projects · IT
- HELSINGIN YLIOPISTO4 projects · FI
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4 projects · UK
- TU/e4 projects · NL
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4 projects · UK
- CSIC3 projects · ES
Projects
Page 20 of 20
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Large-scale platform for motion detection and fluorescence imaging in zebrafish models of neurological disorders PhenoTECH · 899262 | H2020 | €150,000 | €0 | Details |
A diagnostic device for personalized determination of vitamin B6 status and health B6VitaStat · 875594 | H2020 | €150,000 | €0 | Details |
Greenhouse gases to valuable liquid chemicals: High-flux zeolite membrane-based reactor for the efficient conversion of CH4 and CO2 ZeoMemRx · 862283 | H2020 | €150,000 | €0 | Details |
Commercialization of 3D histopathological evaluation of osteoarthritis – new tools for therapy monitoring from preclinical testing to hospitals MUOTO · 875658 | H2020 | €150,000 | €0 | Details |
Commercial feasibility of an anti-bacterial treatment ABOLED · 860277 | H2020 | €150,000 | €0 | Details |
Extended short-wave infrared pulsed fibre laser SWIP · 862254 | H2020 | €150,000 | €0 | Details |
Decreasing Pancreatic Adenocarcinoma-related Inflammation using small molecule inhibitors of STING DIM-CrIC · 893772 | H2020 | €150,000 | €0 | Details |
PEPTICHIP: Streamlined identification of tumour neoantigens for personalised anti-cancer immunotherapy PeptiCHIP · 861947 | H2020 | €150,000 | €0 | Details |
Safe Networks using P4 Programs SafeNet · 875690 | H2020 | €150,000 | €0 | Details |